Patient Square Capital bankrolled a new portfolio company, Elevage Medical Technologies, with $300 million to provide capital and strategic expertise to promising medical device companies. Evan Melrose, founding managing director of Spindletop Capital and a practicing family medicine physician, will lead Elevage. Read More
Companies such asMedtronic plc have become risk averse and are unlikely to takeover early stage medtech firms, Ori Hadomi, vice president strategic initiatives & partnerships, at Medtronic, told delegates at the LSX World Congress in London. Hadomi, who joined Dublin-based Medtronic after his firm Mazor Robotics Inc. was taken over by the company in a $1.64 billion deal in 2018, told early-stage startups “don’t waste their time” in approaching the company. Read More
Bausch + Lomb Corp. reported its U.S. launch of an ophthalmic viscosurgical device (OVD) designed to protect patients during cataract surgery. The Totalvisc viscoelastic system is a dual action chemical protection system that employs viscoelastics which have the properties of both a fluid and an elastic. Unlike its competitors it also features sorbitol to eliminate free radicals that cause oxidative damage in eye tissue. Read More
While sorting out a second phase III study design for its cancer therapy and light device with the U.S. FDA, Soligenix Inc. produced positive results from a compatibility study evaluating Hybryte (synthetic hypericin sodium) for treating early stage cutaneous T-cell lymphoma (CTCL). That data, according to Soligenix, bolster findings from the phase III FLASH study, which used the same combination in treating CTCL. According to Christopher Schaber, Soligenix CEO, the important corporate objectives for the compatibility study were to replicate results seen in the FLASH study. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio Medical, Medalliance, Mivi Neuroscience, Oncohost, Thermo Fisher Scientific, Werfen. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cognixion, Formus Labs, Foundation Medicine. Read More